The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Serum bilirubin as a prognostic marker in patients with acute decompensated heart failure

  • Chintanaboina, Jayakrishna (Department of Internal Medicine, Wright Center for Graduate Medical Education) ;
  • Haner, Matthew S. (Department of Mathematics and Computer Information Science, Mansfield University) ;
  • Sethi, Arjinder (Department of Cardiology, Wright Center for Graduate Medical Education) ;
  • Patel, Nimesh (Department of Internal Medicine, Wright Center for Graduate Medical Education) ;
  • Tanyous, Walid (Department of Internal Medicine, Wright Center for Graduate Medical Education) ;
  • Lalos, Alexander (Gastrointestinal Consultants of NEPA) ;
  • Pancholy, Sameer (Department of Cardiology, Wright Center for Graduate Medical Education)
  • Published : 2013.05.01
⟨ Previous Next ⟩

Abstract

Background/Aims: Several prognostic markers for heart failure (HF) have been determined but the importance of liver function tests (LFTs) remains unknown. The aim of this study was to determine the prognostic significance, if any, of abnormal LFTs in acute decompensated HF. Methods: All adult patients (> 18 years of age) who were admitted to a community hospital with a diagnosis of acute decompensated HF during the period January 2008 to December 2009 were identified. Exclusion criteria included acute coronary syndrome, active hepatobiliary disease, renal failure (serum creatinine ${\geq}$ 2 mg/dL), and malignancy. The primary end point was readmission secondary to acute exacerbation of HF. The Cox proportional hazard model was used for statistical analyses. Results: Univariate analysis showed that serum total bilirubin (TB, p < 0.01), serum B-type natriuretic peptide (p < 0.05), ejection fraction (EF, p < 0.05), and heart rate (p < 0.05) were significant predictors of hospital readmission secondary to acute decompensated HF. Multivariate analysis showed that high serum TB (> 1.3 mg/dL) on admission was an independent predictor (p < 0.05) of hospital readmission secondary to HF. The 'at-risk' group-patients with serum TB > 1.3 mg/dL and/or EF < 35% on admission-had a readmission rate that was $87%{\pm}20%$ (p < 0.05) higher than those with neither criterion. Conclusions: In patients with acute decompensated HF, elevated serum TB on admission with or without low EF (< 35%) predicts a worse prognosis and early future readmission, secondary to HF.

Keywords

References

  1. Liu L. Changes in cardiovascular hospitalization and comorbidity of heart failure in the United States: findings from the National Hospital Discharge Surveys 1980-2006. Int J Cardiol 2011;149:39-45. https://doi.org/10.1016/j.ijcard.2009.11.037
  2. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360:1418-1428. https://doi.org/10.1056/NEJMsa0803563
  3. Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 2002;90:1405-1409. https://doi.org/10.1016/S0002-9149(02)02886-2
  4. Dunn GD, Hayes P, Breen KJ, Schenker S. The liver in congestive heart failure: a review. Am J Med Sci 1973;265:174-189. https://doi.org/10.1097/00000441-197303000-00001
  5. Sherlock S. The liver in heart failure: relation of anatomical, functional, and circulatory changes. Br Heart J 1951;13:273-293. https://doi.org/10.1136/hrt.13.3.273
  6. Batin P, Wickens M, McEntegart D, Fullwood L, Cowley AJ. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 1995;16:1613-1618. https://doi.org/10.1093/oxfordjournals.eurheartj.a060785
  7. Fuhrmann V, Kneidinger N, Herkner H, et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 2009;35:1397-1405. https://doi.org/10.1007/s00134-009-1508-2
  8. Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 2009;11:170-177. https://doi.org/10.1093/eurjhf/hfn031
  9. Shinagawa H, Inomata T, Koitabashi T, et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J 2008;72:364-369. https://doi.org/10.1253/circj.72.364
  10. Bynum TE, Boitnott JK, Maddrey WC. Ischemic hepatitis. Dig Dis Sci 1979;24:129-135. https://doi.org/10.1007/BF01324740

Cited by

  1. Can the liver tell us about the heart? An old story revisited vol.28, pp.3, 2013, https://doi.org/10.3904/kjim.2013.28.3.292
  2. Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopa vol.29, pp.6, 2014, https://doi.org/10.1007/s00380-013-0415-1
  3. Usefulness of serum bilirubin levels as a biomarker for long-term clinical outcomes after percutaneous coronary intervention vol.30, pp.6, 2015, https://doi.org/10.1007/s00380-014-0546-z
  4. Prognostic Value of Prothrombin Time International Normalized Ratio in Acute Decompensated Heart Failure - A Combined Marker of Hepatic Insufficiency and Hemostatic Abnormality - vol.80, pp.4, 2013, https://doi.org/10.1253/circj.cj-15-1326
  5. Renal vein dilation predicts poor outcome in patients with refractory cirrhotic ascites vol.48, pp.3, 2013, https://doi.org/10.1111/hepr.12935
  6. Laboratory prognostic score for predicting 14-day mortality in terminally ill patients with gynecologic malignancy vol.26, pp.7, 2013, https://doi.org/10.1007/s10147-021-01923-x